• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与猫I型和VI型粘多糖贮积症相关的心血管异常的临床特征

Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI.

作者信息

Sleeper M M, Kusiak C M, Shofer F S, O'Donnell P, Bryan C, Ponder K P, Haskins M E

机构信息

Section of Cardiology, Department of Clinical Studies, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.

出版信息

J Inherit Metab Dis. 2008 Jun;31(3):424-31. doi: 10.1007/s10545-008-0821-1. Epub 2008 May 23.

DOI:10.1007/s10545-008-0821-1
PMID:18509743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2682766/
Abstract

OBJECTIVE

The purpose of this study was to define the cardiovascular abnormalities present in young and adult cats affected with the lysosomal storage diseases mucopolysaccharidosis (MPS) I and MPS VI.

METHOD

Eighteen cats affected with MPS I and 10 cats affected with MPS VI were evaluated by physical examination, electrocardiography and echocardiography. Electrocardiography (ECG) was performed on all MPS I and 9 of the MPS VI cats. Twelve unaffected cats underwent complete examinations for comparison purposes.

RESULTS

No cardiovascular abnormalities were noted on physical examination. Measured ECG intervals were normal in affected cats; however, sinus arrhythmia was noted more frequently than in the unaffected cats. Significant echocardiographic abnormalities included aortic valve thickening, regurgitation and aortic root dilation. Significant mitral valve thickening was also noted. The severity of changes increased in older affected cats.

CONCLUSION

As affected animals increased in age, more cardiac abnormalities were found with increasing severity. Significant lesions included the mitral and aortic valves and ascending aorta, but myocardial changes were not recognized. MPS I and MPS VI cats have similar cardiovascular findings to those seen in children and constitute important models for testing new MPS therapies.

摘要

目的

本研究旨在明确患有溶酶体贮积病黏多糖贮积症(MPS)I型和MPS VI型的幼年及成年猫所存在的心血管异常情况。

方法

对18只患有MPS I型的猫和10只患有MPS VI型的猫进行体格检查、心电图检查和超声心动图检查。对所有患有MPS I型的猫以及9只患有MPS VI型的猫进行了心电图(ECG)检查。为作比较,对12只未受影响的猫进行了全面检查。

结果

体格检查未发现心血管异常。受影响猫的心电图测量间期正常;然而,窦性心律失常的出现频率高于未受影响的猫。显著的超声心动图异常包括主动脉瓣增厚、反流和主动脉根部扩张。还发现二尖瓣显著增厚。随着受影响猫年龄增长,变化的严重程度增加。

结论

随着受影响动物年龄增长,发现的心脏异常越来越多,且严重程度不断增加。显著病变包括二尖瓣、主动脉瓣和升主动脉,但未发现心肌变化。患有MPS I型和MPS VI型的猫具有与儿童相似的心血管表现,是测试新型MPS疗法的重要模型。

相似文献

1
Clinical characterization of cardiovascular abnormalities associated with feline mucopolysaccharidosis I and VI.与猫I型和VI型粘多糖贮积症相关的心血管异常的临床特征
J Inherit Metab Dis. 2008 Jun;31(3):424-31. doi: 10.1007/s10545-008-0821-1. Epub 2008 May 23.
2
Altered olfactory epithelial structure and function in feline models of mucopolysaccharidoses I and VI.黏多糖贮积症I型和VI型猫模型中嗅觉上皮结构和功能的改变
J Comp Neurol. 2008 Nov 20;511(3):360-72. doi: 10.1002/cne.21847.
3
[Echocardiographic findings in 3 cases of mucopolysaccharidosis].
J Cardiogr. 1983 Mar;13(1):171-80.
4
Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII.黏多糖贮积症I型、VI型和VII型猫科和犬科模型中糖胺聚糖的肝脏储存情况。
Vet Pathol. 1992 Mar;29(2):112-9. doi: 10.1177/030098589202900203.
5
[Cardiovascular findings and effects of enzyme replacement therapy in patients with mucopolysaccharidosis type VI].[心血管系统表现及酶替代疗法对 VI 型黏多糖贮积症患者的影响]
Turk Kardiyol Dern Ars. 2019 Oct;47(7):587-593. doi: 10.5543/tkda.2019.44502.
6
Intrathecal recombinant human 4-sulfatase reduces accumulation of glycosaminoglycans in dura of mucopolysaccharidosis VI cats.鞘内注射重组人 4-硫酸酯酶可减少黏多糖贮积症 VI 型猫硬脑膜中糖胺聚糖的蓄积。
Pediatr Res. 2012 Jan;71(1):39-45. doi: 10.1038/pr.2011.13.
7
Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation.黏多糖贮积症 VI 型:一例以胎儿腹水和快速进展性心脏表现为首发表现的新生儿病例报告。
BMC Med Genet. 2020 Feb 19;21(1):37. doi: 10.1186/s12881-020-0972-y.
8
Aortic Root Dilatation in Mucopolysaccharidosis I-VII.黏多糖贮积症I - VII型中的主动脉根部扩张
Int J Mol Sci. 2016 Nov 29;17(12):2004. doi: 10.3390/ijms17122004.
9
Cardiac manifestations of the mucopolysaccharidoses.黏多糖贮积症的心脏表现
Circulation. 1975 Oct;52(4):700-5. doi: 10.1161/01.cir.52.4.700.
10
Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI.角膜基质组织改变与黏多糖贮积症I型、III型和VI型相关。
Exp Eye Res. 1999 May;68(5):523-30. doi: 10.1006/exer.1998.0622.

引用本文的文献

1
Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.N-乙酰半乳糖胺-4-硫酸酯酶(芳基硫酸酯酶 B)下降对分子病理生理学和人类疾病的深远影响。
Int J Mol Sci. 2022 Oct 29;23(21):13146. doi: 10.3390/ijms232113146.
2
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.黏多糖贮积症 I 型:自然病史和分子病理学综述。
Cells. 2020 Aug 5;9(8):1838. doi: 10.3390/cells9081838.
3
Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases.基因治疗对溶酶体贮积症心血管症状的影响。
Genet Mol Biol. 2019;42(1 suppl 1):261-285. doi: 10.1590/1678-4685-GMB-2018-0100. Epub 2019 May 23.
4
Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies
.人类遗传疾病的犬类和猫科动物模型及其对推进临床治疗的贡献
Yale J Biol Med. 2017 Sep 25;90(3):417-431. eCollection 2017 Sep.
5
Aortic Root Dilatation in Mucopolysaccharidosis I-VII.黏多糖贮积症I - VII型中的主动脉根部扩张
Int J Mol Sci. 2016 Nov 29;17(12):2004. doi: 10.3390/ijms17122004.
6
Mucopolysaccharidosis VI in cats - clarification regarding genetic testing.猫的黏多糖贮积症VI型——关于基因检测的说明
BMC Vet Res. 2016 Jul 2;12(1):136. doi: 10.1186/s12917-016-0764-y.
7
Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I.肝脏定向基因治疗可纠正猫 I 型黏多糖贮积症中的心血管病变。
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14894-9. doi: 10.1073/pnas.1413645111. Epub 2014 Sep 29.
8
Sensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI).马罗-拉米综合征(或黏多糖贮积症VI型)动物模型的感觉运动行为特征
Sci Rep. 2014 Jan 10;4:3644. doi: 10.1038/srep03644.
9
Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness.颈动脉内膜中层厚度在接受治疗的黏多糖贮积症 I 型和 II 型患者中增加,并与动脉僵硬度相关。
Mol Genet Metab. 2014 Feb;111(2):128-32. doi: 10.1016/j.ymgme.2013.11.001. Epub 2013 Nov 12.
10
Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats.用γ逆转录病毒载体对黏多糖贮积症 VI 型猫进行新生儿基因治疗。
Mol Ther. 2012 May;20(5):898-907. doi: 10.1038/mt.2012.9. Epub 2012 Mar 6.

本文引用的文献

1
Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig.黏多糖贮积症I型猫在新生期基因治疗后会产生细胞毒性T淋巴细胞反应,这种反应可被CTLA4-Ig阻断。
Mol Ther. 2006 Jul;14(1):5-13. doi: 10.1016/j.ymthe.2006.03.015. Epub 2006 May 12.
2
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.人类退行性瓣膜病与低密度脂蛋白受体相关蛋白5受体介导的骨形成上调有关。
J Am Coll Cardiol. 2006 Apr 18;47(8):1707-12. doi: 10.1016/j.jacc.2006.02.040. Epub 2006 Mar 20.
3
Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI.28例VI型黏多糖贮积症患者的临床与生化研究。
Clin Genet. 2004 Sep;66(3):208-13. doi: 10.1111/j.1399-0004.2004.00277.x.
4
Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII.基因疗法改善了患有黏多糖贮积症VII型犬的心血管疾病。
Circulation. 2004 Aug 17;110(7):815-20. doi: 10.1161/01.CIR.0000138747.82487.4B. Epub 2004 Aug 2.
5
Gene therapy for lysosomal storage diseases: the lessons and promise of animal models.溶酶体贮积症的基因治疗:动物模型的经验与前景
J Gene Med. 2004 May;6(5):481-506. doi: 10.1002/jgm.581.
6
Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs.黏多糖贮积症VII型犬的新生儿肝脏治疗性基因疗法。
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13102-7. doi: 10.1073/pnas.192353499. Epub 2002 Sep 13.
7
Enzyme replacement therapy in feline mucopolysaccharidosis I.猫黏多糖贮积症I型的酶替代疗法。
Mol Genet Metab. 2001 Mar;72(3):199-208. doi: 10.1006/mgme.2000.3140.
8
Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII.骨髓移植对犬黏多糖贮积症VII型心血管异常的影响。
Bone Marrow Transplant. 2000 Jun;25(12):1289-97. doi: 10.1038/sj.bmt.1702448.
9
Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients.黏多糖贮积病及相关疾病患儿的心血管变化——64例患者的临床及超声心动图表现
Eur J Pediatr. 1998 Jul;157(7):534-8. doi: 10.1007/s004310050872.
10
Mucopolysaccharidosis presenting as pediatric multiple aortic aneurysm: first reported case.
J Vasc Surg. 1997 Oct;26(4):704-10. doi: 10.1016/s0741-5214(97)70074-0.